Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Cancers|July 2, 2021
Intensified Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Anus-A Population-Based Experience from the Danish Anal Cancer GroupKaren Lycke Wind, Lisbeth Riber, Birgitte Mayland Havelund, et al.
Acta Oncologica (Stockholm, Sweden)|May 11, 2026
Real-world outcomes of pembrolizumab in advanced anal cancer: a nationwide Danish anal Cancer Group reportKaren-Lise Garm Spindler, Christian Andreas Hvid, Lars Ulrik Fokdal, et al.
Rheumatology (Oxford, England)|May 20, 2021
Diagnostic accuracy of high-resolution peripheral quantitative computed tomography and X-ray for classifying erosive rheumatoid arthritisRasmus Klose-Jensen, Josephine Therkildsen, Anne-Birgitte Garm Blavnsfeldt, et al.
Technical Innovations & Patient Support in Radiation Oncology|February 24, 2026
Shared decision-making in radiotherapy for rectal cancer - A systematic reviewLise Kjær Schou, Anne Wilhøft Kristensen, Johanne Hollands Steffensen, et al.
Plos One|June 20, 2017
Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlationsAhmed Hussein Zedan, Søren Garm Blavnsfeldt, Torben Frøstrup Hansen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 30, 2018
Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancerKaren-Lise Garm Spindler, Christina Demuth, Boe Sandahl Sorensen, et al.
Acta Oncologica (Stockholm, Sweden)|September 16, 2025
Predictors of acute and late diarrhea in the treatment of anal cancer with concurrent chemoradiotherapyKatrine Smedegaard Storm, Karen-Lise Garm Spindler, Gitte Fredberg Persson, et al.
Journal of Cardiovascular Computed Tomography|July 2, 2024
Biomarkers for identification of high-risk coronary artery plaques in patients with suspected coronary artery diseaseGitte Pedersen, Jonathan Nørtoft Dahl, Laust Dupont Rasmussen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT TrialA Johnsson, H Hagman, J-E Frödin, et al.
International Journal of Cancer|May 7, 2021
Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancerJulian Hamfjord, Tormod Kyrre Guren, Bengt Glimelius, et al.
Pageof 17